Policies and Procedures
Institutional health and Biosafety Committee (IHBC)
- An Institutional Biosafety Committee (IBC) is required at institutions that receive funding from the National Institutes of Health (NIH) for research involving recombinant DNA molecules. All recombinant DNA research at Emory University, regardless of funding source, must be conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules (http://www4.od.nih.gov/oba/guidelines.html) and must be registered with the IBC.
- The Emory Institutional Health and Biosafety Committee (IHBC) is charged with reviewing and approving research conducted with, but not limited to, biological toxins, recombinant DNA, human cell, tissues, microorganisms pathogenic to humans, plants, or animals. This is regardless of the funding sources. The Emory IHBC will also provide guidance to the research community regarding proper acquisition, handling, transfer, and disposal of potentially hazardous or regulated biological materials.
Chemical Hygiene Plan
Food and Drinks Guideline
Guidelines for Chemical Waste Disposal In Laboratories
IHBC 2009 Meeting Schedule
IHBC Policies and Procedures
Protocol Approval Process
Sharps Guidelines
University Policy on Immunization